Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T lymphocytes, or T cells, are a fundamental lineage of white blood cells that play a central role in the adaptive immune response (StatPearls: T-Cell Lymphocytes, 2023). Originating from hematopoietic stem cells in the bone marrow and maturing in the thymus, these cells are distinguished by the presence of a T-cell receptor (TCR) on their surface (Wikipedia: T cell, 2024). Polyclonal T lymphocytes refer to a heterogeneous population of T cells with a diverse repertoire of TCRs, enabling the recognition of a wide array of antigens (Nature Reviews Immunology: T cell functions, 2021). In therapeutic contexts, this population is often targeted for depletion using polyclonal antibodies like anti-thymocyte globulin (ATG) to prevent or treat organ transplant rejection and graft-versus-host disease (StatPearls: Antithymocyte Globulin, 2023). Additionally, the expansion of polyclonal T cells is a critical step in adoptive cell therapies, such as tumor-infiltrating lymphocyte (TIL) therapy, where the cells are harvested, activated, and re-infused to combat malignancies (NCI: TIL Therapy, 2023). Pharmacological modulation of T cells, whether through immunosuppression in autoimmune diseases or activation in cancer immunotherapy, remains a primary strategy in modern medicine (PubMed: T cell modulation, 2022).
T-cell depletion via complement-dependent cytotoxicity and opsonization; inhibition of T-cell receptor signaling and IL-2 mediated proliferation (StatPearls: Antithymocyte Globulin, 2023; NIH: Immunosuppressive Agents, 2022).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T lymphocyte (T cell) (T cell).